Page last updated: 2024-11-13
11-o-debenzoyltashironin
Description
11-O-Debenzoyltashironin is a **natural product** isolated from the plant **Tashironin**. It's a **modified alkaloid** with a complex structure, and its chemical name is **(11S,12S)-12-hydroxy-11-methyl-11,12-dihydro-3,7-dimethoxy-11-O-debenzoyl-4-methoxyaporphine**.
Here's why it's important for research:
* **Pharmacological potential:** 11-O-Debenzoyltashironin has shown **biological activity**, including **antioxidant, anti-inflammatory, and neuroprotective properties** in preliminary studies. This makes it a potential candidate for developing new drugs or therapies.
* **Structural complexity:** The molecule has a complex and unique structure, which makes it a fascinating target for **chemical synthesis and drug discovery research**. Understanding its structure and how it interacts with biological systems can lead to new insights in medicinal chemistry.
* **Biodiversity:** 11-O-Debenzoyltashironin's isolation from Tashironin highlights the potential of natural products as sources for novel compounds with therapeutic potential. Exploring the chemical diversity of plants and other organisms can open doors to exciting new discoveries in drug discovery.
However, it's important to note that:
* **Research on 11-O-Debenzoyltashironin is still in its early stages.** More research is needed to fully understand its pharmacological properties, safety, and potential therapeutic applications.
* **It is not yet available as a medicine.** It is a research compound, and it is not approved for any medical use.
Overall, 11-O-Debenzoyltashironin is a promising natural product with potential applications in medicine and drug discovery. Further research is needed to explore its therapeutic potential and fully understand its biological activity.
11-O-debenzoyltashironin: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
Synonyms (2)
Synonym |
11-o-debenzoyltashironin |
CHEMBL442573 |
Research
Studies (8)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (62.50) | 29.6817 |
2010's | 2 (25.00) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.20
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 12.20 (24.57) | Research Supply Index | 2.20 (2.92) | Research Growth Index | 4.40 (4.65) | Search Engine Demand Index | 0.00 (26.88) | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 1 (12.50%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 7 (87.50%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |